Literature DB >> 21945659

Ground-glass opacity lesions on computed tomography during postoperative surveillance for primary non-small cell lung cancer.

Akira Haro1, Tokujiro Yano, Mikihiro Kohno, Tsukihisa Yoshida, Tatsuro Okamoto, Yoshihiko Maehara.   

Abstract

Improvement in chest high-resolution computed tomography (CT) has increased the detection of ground-glass opacity (GGO) lesions. However, there is no clear therapeutic consensus about concurrent GGO lesions detected during postoperative follow-up chest CT after treatment for primary lung cancer. This study retrospectively and prospectively investigated 21 patients in whom 53 GGO lesions were detected during postoperative follow-up CT of non-small cell lung cancer at Kyushu University Hospital from April 2009 to February 2010. We investigated clinicopathological factors, such as age, gender, lesion number, size, laterality, time of identification, and enlargement or emergence of the inner solid component. The malignancy rate of the concurrent GGO lesions was assessed by log-rank test in the Kaplan-Meier curves. Twenty percent of the 53 GGO lesions had malignant radiological findings during the 5-year follow-up after they were first identified by CT. The newly emerging GGO lesions at postoperative CT had significantly more malignant radiological findings (39.5%) than other GGO lesions (9.5%). Three potentially malignant GGO lesions were treated by surgical resection and three were treated by stereotactic radiotherapy. These six treated GGO lesions showed a good clinical course without recurrence after treatment. Special attention should be paid to newly emerging GGO lesions after resection of primary non-small cell lung cancer. It is necessary to select an appropriate treatment, taking account of various factors such as the laterality and number of GGO lesions or the pathological stage of the postoperative lung cancer. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21945659     DOI: 10.1016/j.lungcan.2011.09.002

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  7 in total

Review 1.  Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Authors:  Yoshihisa Kobayashi; Tetsuya Mitsudomi
Journal:  Transl Lung Cancer Res       Date:  2013-10

2.  Long-term results after surgical treatment of the dominant lung adenocarcinoma associated with ground-glass opacities.

Authors:  Stefano Bongiolatti; Roberto Corzani; Sara Borgianni; Fabiola Meniconi; Fabrizio Cipollini; Alessandro Gonfiotti; Domenico Viggiano; Piero Paladini; Luca Voltolini
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

3.  Can we differentiate minimally invasive adenocarcinoma and non-invasive neoplasms based on high-resolution computed tomography features of pure ground glass nodules?

Authors:  Xiaoye Wang; Lihua Wang; Weisheng Zhang; Hong Zhao; Feng Li
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

4.  Dynamic Observation of Lung Nodules on Chest CT Before Diagnosis of Early Lung Cancer.

Authors:  Qiaodan Du; Jia Peng; Xiuyu Wang; MingFang Ji; Yuting Liao; Binghang Tang
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

5.  Diagnosis of the invasiveness of lung adenocarcinoma manifesting as ground glass opacities on high-resolution computed tomography.

Authors:  Haixia Mao; Kanchan Labh; Fushi Han; Sen Jiang; Yang Yang; Xiwen Sun
Journal:  Thorac Cancer       Date:  2015-04-27       Impact factor: 3.500

6.  Analysis of risk factors for stage I lung adenocarcinoma using low-dose high-resolution computed tomography.

Authors:  Rui Fang; Yong Yang; Haicheng Han; Xiaoqing Fu; Liwen Dong; Baisheng Xie; Wei Lu; Chenyang Ma; Feng Cui; Jian Hu; Jun Wang
Journal:  Oncol Lett       Date:  2018-06-06       Impact factor: 2.967

7.  Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity.

Authors:  Hiroshi Onishi; Yoshiyuki Shioyama; Yasuo Matsumoto; Yuta Shibamoto; Akifumi Miyakawa; Gen Suzuki; Yasumasa Nishimura; Ryohei Sasaki; Daisuke Miyawaki; Kengo Kuriyama; Takafumi Komiyama; Kan Marino; Shinichi Aoki; Ryo Saito; Masayuki Araya; Yoshiyasu Maehata; Hotaka Nonaka; Licht Tominaga; Masahide Saito; Naoki Sano; Shogo Yamada
Journal:  J Radiat Res       Date:  2020-05-22       Impact factor: 2.724

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.